Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$25.45 - $37.46 $49,398 - $72,709
1,941 New
1,941 $53,000
Q2 2023

Jul 18, 2023

BUY
$30.29 - $38.28 $15,023 - $18,986
496 Added 77.5%
1,136 $38,000
Q1 2023

Apr 13, 2023

BUY
$34.78 - $47.43 $1,704 - $2,324
49 Added 8.29%
640 $23,000
Q4 2022

Jan 23, 2023

SELL
$27.78 - $45.38 $361 - $589
-13 Reduced 2.15%
591 $0
Q3 2022

Oct 26, 2022

SELL
$22.7 - $37.57 $40,837 - $67,588
-1,799 Reduced 74.86%
604 $16,000
Q2 2022

Jul 25, 2022

SELL
$20.5 - $37.33 $435,215 - $792,515
-21,230 Reduced 89.83%
2,403 $64,000
Q1 2022

May 02, 2022

BUY
$27.64 - $39.32 $9,231 - $13,132
334 Added 1.43%
23,633 $804,000
Q4 2021

Jan 28, 2022

BUY
$35.68 - $56.27 $831,308 - $1.31 Million
23,299 New
23,299 $900,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.22B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.